The impact of the FilmArray meningitis/encephalitis panel on empiric antibiotic prescriptions in patients with suspected community-acquired meningitis
- PMID: 39559291
- PMCID: PMC11570331
- DOI: 10.1017/ash.2024.343
The impact of the FilmArray meningitis/encephalitis panel on empiric antibiotic prescriptions in patients with suspected community-acquired meningitis
Abstract
The BioFire® FilmArray® meningitis/encephalitis (FA/ME) panel provides rapid testing for common cerebrospinal fluid pathogens. We compared empiric antibiotic utilization between patients with suspected community-acquired meningitis with and without an FA/ME panel ordered. No significant differences in antibiotic use were found.
© The Author(s) 2024.
Conflict of interest statement
All authors report no conflicts of interest relevant to this article.
References
-
- Hasbun R. Progress and challenges in bacterial meningitis: a review. JAMA 2022;328:2147–2154. - PubMed
-
- Fiore AE, Moroney JF, Farley MM, et al. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clinical Infectious Diseases 2000;30:71–77. - PubMed
-
- Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clinical Microbiology and Infection 2016;22:416–422. - PubMed
-
- Pulingam T, Parumasivam T, Gazzali AM, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. European Journal of Pharmaceutical Sciences 2022;170:106103. - PubMed
LinkOut - more resources
Full Text Sources